Comment on: ‘Effects of age, sex, daily dose, comorbidity and co-medication on venlafaxine-associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA adverse event reporting system database’.

HOME
>
論文・技術情報
>
Comment on: ‘Effects of age, sex, daily dose, comorbidity and co-medication on venlafaxine-associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA adverse event reporting system database’.

アブストラクト
ジャーナル名	British journal of clinical pharmacology
Pubmed追加日	2025/5/30
投稿者	Masuda, Rikuto; Noguchi, Yoshihiro; Kobayashi, Ryo; Yoshimura, Tomoaki
組織名	Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.;Laboratory of Advanced Medical Pharmacy, Gifu Pharmaceutical University, Gifu,;Japan.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40441685/